Mechanical Circulatory Support as a Bridge to Transplant or for Destination Therapy

Mechanical circulatory support (MCS) frequently is used to treat medically refractory end-stage heart failure. Initially designed to be a bridge to transplantation, MCS also has proven itself as a durable therapy for patients who are not transplant candidates. As outcomes for patients with MCS have...

Full description

Saved in:
Bibliographic Details
Published in:Current heart failure reports 2010-12, Vol.7 (4), p.159-166
Main Authors: Shreenivas, Satya S., Rame, J. Eduardo, Jessup, Mariell
Format: Article
Language:English
Subjects:
Cardiac Surgery
Cardiology
Contraindications
Equipment Design - instrumentation
Equipment Design - trends
Evaluation Studies as Topic
Heart Failure - complications
Heart Failure - mortality
Heart Failure - physiopathology
Heart Failure - therapy
Heart Transplantation - instrumentation
Heart-Assist Devices - adverse effects
Heart-Assist Devices - classification
Humans
Imaging
Internal Medicine
Medicine
Medicine & Public Health
Outcome Assessment, Health Care
Patient Selection
Radiology
Severity of Illness Index
Shock - etiology
Shock - physiopathology
Shock - therapy
Vascular Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mechanical circulatory support (MCS) frequently is used to treat medically refractory end-stage heart failure. Initially designed to be a bridge to transplantation, MCS also has proven itself as a durable therapy for patients who are not transplant candidates. As outcomes for patients with MCS have improved, research interest in device development has flourished, with many new device types under investigation. In addition to improvement of MCS devices, investigational work continues to achieve appropriate patient selection and complication management.
ISSN:1546-9530
1546-9549
DOI:10.1007/s11897-010-0026-4